{"id":859377,"date":"2025-06-11T07:03:09","date_gmt":"2025-06-11T11:03:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/"},"modified":"2025-06-11T07:03:09","modified_gmt":"2025-06-11T11:03:09","slug":"ligand-announces-2025-investor-day-in-new-york-city","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/","title":{"rendered":"Ligand Announces 2025 Investor Day in New York City"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">JUPITER, Fla., June  11, 2025  (GLOBE NEWSWIRE) &#8212; Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will host an Investor Day in New York City on Tuesday, December 9, 2025 at 10 a.m. Eastern Time at the Harvard Club.<\/p>\n<p align=\"justify\">The event will include presentations from Ligand\u2019s senior management team highlighting the company\u2019s strategy, investment activity, royalty portfolio, and long-term financial outlook. A live webcast of the event will be accessible through Ligand\u2019s Investor Relations website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2eFTZ4Vz4ru0s_mkM644WYyjnrlo2y9REARSafp4pU-TV_b_5wEhW7zWf8D-Xkp3I1v_i10dLnWF1nCBMtqkl6i4aKP_aeUG2tlrqSxKPmxnPq8qT-WAOfDRt0z7lyci\" rel=\"nofollow\" target=\"_blank\">investor.ligand.com<\/a>. A detailed agenda, including dial-in information, will be provided closer to the event.<\/p>\n<p align=\"justify\">\n        <strong>About Ligand Pharmaceuticals<\/strong><br \/>\n        <br \/>Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, licensing our technologies or both. Our business model seeks to generate value for stockholders by creating a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable and diversified manner. Our business model is based on funding programs in mid- to late-stage drug development in return for economic rights, purchasing royalty rights in development stage or commercial biopharmaceutical products and licensing our technology to help partners discover and develop medicines. We partner with other pharmaceutical companies to attempt to leverage what they do best (late-stage development, regulatory management and commercialization) in order to generate our revenue. We operate two infrastructure-light royalty generating technology IP platform technologies. Our Captisol\u00ae platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Our NITRICIL\u2122 platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a broad range of indications. We have established multiple alliances, licenses and other business relationships with the world\u2019s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Gilead Sciences and Baxter International. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xeB_7Eqxeclgjm2_SCfzKpESsOeFpqv6k2yiMDRvOA8LPNMKtqlmAYKfAkejgXZ3YAtIm5Vg5zNEMV9UMmqjkg==\" rel=\"nofollow\" target=\"_blank\">www.ligand.com<\/a>. Follow Ligand on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4myimHQY4G6XXFXst_6x0rYkudYlR0E60QzNm4SRZLjr9qgiy5oPdt87mVsi1cPF1qF4wfFEZIcQ5WUO8ZFqaw==\" rel=\"nofollow\" target=\"_blank\">X<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wQMfXV3-C8MybB1bcovWi6eRUSK9IRhc6JO76PsedglS-0y2zwRqUtM4w_H8M3j4A2yo1mDoPEFlHlnGoUhRtJOcxTZV2l6EBHMMHCkpFQQ3RFJcQe68OtclOnTCLMXH\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p align=\"justify\">We use our investor relations website and X as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Investors should monitor our website and our X account, in addition to following our press releases, SEC filings, public conference calls and webcasts.<\/p>\n<p align=\"justify\">\n        <strong>Contacts<\/strong><br \/>\n        <br \/>Investors:<br \/>Melanie Herman<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2eFTZ4Vz4ru0s_mkM644WbeVg_YJPJNOgTGEtg3LVuOdqFX7fxto6VW1Vl3npVMdCVVzHDLoifrXwhJew8n-YdqXrxm1XyBK83gJ4b0VK3U=\" rel=\"nofollow\" target=\"_blank\">investors@ligand.com<\/a><br \/>(858) 550-7761<\/p>\n<p align=\"justify\">Media: <br \/>Kellie Walsh<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qsnj9Fc4ioTxdC0bNjjlQdKqiPzbHkNcqQ4VgqNUloIhWMuquFaOgDnBRQRbYAC1glZ-y44s-Wn41RBzYl3ITpSWUNSas8rcmwdy3iHU19M=\" rel=\"nofollow\" target=\"_blank\">media@ligand.com<\/a><br \/>(914) 315-6072<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NjY2MCM2OTg1MzgxIzIwMDY1NjQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NGY2OGFiODAtMWQ0OS00OGUwLTkzMDAtNDI2ZGRhM2E4MjRiLTEwMTgxMzctMjAyNS0wNi0xMS1lbg==\/tiny\/Ligand-Pharmaceuticals.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>JUPITER, Fla., June 11, 2025 (GLOBE NEWSWIRE) &#8212; Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will host an Investor Day in New York City on Tuesday, December 9, 2025 at 10 a.m. Eastern Time at the Harvard Club. The event will include presentations from Ligand\u2019s senior management team highlighting the company\u2019s strategy, investment activity, royalty portfolio, and long-term financial outlook. A live webcast of the event will be accessible through Ligand\u2019s Investor Relations website at investor.ligand.com. A detailed agenda, including dial-in information, will be provided closer to the event. About Ligand Pharmaceuticals Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, licensing our technologies or &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ligand Announces 2025 Investor Day in New York City&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-859377","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ligand Announces 2025 Investor Day in New York City - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ligand Announces 2025 Investor Day in New York City - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"JUPITER, Fla., June 11, 2025 (GLOBE NEWSWIRE) &#8212; Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will host an Investor Day in New York City on Tuesday, December 9, 2025 at 10 a.m. Eastern Time at the Harvard Club. The event will include presentations from Ligand\u2019s senior management team highlighting the company\u2019s strategy, investment activity, royalty portfolio, and long-term financial outlook. A live webcast of the event will be accessible through Ligand\u2019s Investor Relations website at investor.ligand.com. A detailed agenda, including dial-in information, will be provided closer to the event. About Ligand Pharmaceuticals Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, licensing our technologies or &hellip; Continue reading &quot;Ligand Announces 2025 Investor Day in New York City&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-11T11:03:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NjY2MCM2OTg1MzgxIzIwMDY1NjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-announces-2025-investor-day-in-new-york-city\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-announces-2025-investor-day-in-new-york-city\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ligand Announces 2025 Investor Day in New York City\",\"datePublished\":\"2025-06-11T11:03:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-announces-2025-investor-day-in-new-york-city\\\/\"},\"wordCount\":411,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-announces-2025-investor-day-in-new-york-city\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NjY2MCM2OTg1MzgxIzIwMDY1NjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-announces-2025-investor-day-in-new-york-city\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-announces-2025-investor-day-in-new-york-city\\\/\",\"name\":\"Ligand Announces 2025 Investor Day in New York City - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-announces-2025-investor-day-in-new-york-city\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-announces-2025-investor-day-in-new-york-city\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NjY2MCM2OTg1MzgxIzIwMDY1NjQ=\",\"datePublished\":\"2025-06-11T11:03:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-announces-2025-investor-day-in-new-york-city\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-announces-2025-investor-day-in-new-york-city\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-announces-2025-investor-day-in-new-york-city\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NjY2MCM2OTg1MzgxIzIwMDY1NjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NjY2MCM2OTg1MzgxIzIwMDY1NjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-announces-2025-investor-day-in-new-york-city\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ligand Announces 2025 Investor Day in New York City\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ligand Announces 2025 Investor Day in New York City - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/","og_locale":"en_US","og_type":"article","og_title":"Ligand Announces 2025 Investor Day in New York City - Market Newsdesk","og_description":"JUPITER, Fla., June 11, 2025 (GLOBE NEWSWIRE) &#8212; Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will host an Investor Day in New York City on Tuesday, December 9, 2025 at 10 a.m. Eastern Time at the Harvard Club. The event will include presentations from Ligand\u2019s senior management team highlighting the company\u2019s strategy, investment activity, royalty portfolio, and long-term financial outlook. A live webcast of the event will be accessible through Ligand\u2019s Investor Relations website at investor.ligand.com. A detailed agenda, including dial-in information, will be provided closer to the event. About Ligand Pharmaceuticals Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, licensing our technologies or &hellip; Continue reading \"Ligand Announces 2025 Investor Day in New York City\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-11T11:03:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NjY2MCM2OTg1MzgxIzIwMDY1NjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ligand Announces 2025 Investor Day in New York City","datePublished":"2025-06-11T11:03:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/"},"wordCount":411,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NjY2MCM2OTg1MzgxIzIwMDY1NjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/","name":"Ligand Announces 2025 Investor Day in New York City - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NjY2MCM2OTg1MzgxIzIwMDY1NjQ=","datePublished":"2025-06-11T11:03:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NjY2MCM2OTg1MzgxIzIwMDY1NjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NjY2MCM2OTg1MzgxIzIwMDY1NjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-announces-2025-investor-day-in-new-york-city\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ligand Announces 2025 Investor Day in New York City"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/859377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=859377"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/859377\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=859377"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=859377"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=859377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}